MariMed (MRMD) director awarded 192,308 RSUs converting to shares
Rhea-AI Filing Summary
MARIMED INC. director Allen David R received 192,308 Restricted Stock Units on July 15, 2026 in lieu of a portion of his board fees. The RSUs vested upon grant and converted one-for-one into 192,308 shares of common stock at no cash exercise price, increasing his direct holdings to 743,452 shares. No RSUs from this award remain outstanding.
Positive
- None.
Negative
- None.
Insider Trade Summary
192,308 shares exercised/converted
Mixed
3 txns
Insider
Allen David R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units (RSU) | 192,308 | $0.00 | -- |
| Exercise | Restricted Stock Units (RSU) | 192,308 | $0.00 | -- |
| Exercise | Common stock | 192,308 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units (RSU) — 192,308 shares (Direct);
Common stock — 743,452 shares (Direct)
Footnotes (1)
- RSUs convert to shares of common stock on a one-for-one basis. The RSUs were granted on July 15, 2026 and vested upon grant in accordance with the terms of the award agreement between the Issuer and the Reporting Person. Accordingly, no RSUs remain outstanding under this award.
Key Figures
RSUs granted: 192,308 units
Common shares acquired: 192,308 shares
Total shares held after transaction: 743,452 shares
+2 more
5 metrics
RSUs granted
192,308 units
Restricted Stock Units granted on July 15, 2026 in lieu of board fees
Common shares acquired
192,308 shares
Shares of common stock received upon RSU vesting and conversion on July 15, 2026
Total shares held after transaction
743,452 shares
Direct holdings of MariMed common stock by Allen David R following the RSU conversion
Exercise price per share
$0.00 per share
Cash exercise price for conversion of RSUs into common stock
Underlying common shares per RSU
1 share per RSU
RSUs convert to shares of common stock on a one-for-one basis
Key Terms
Restricted Stock Units (RSU), derivative security, in lieu of cash, Rule 10b5-1
4 terms
Restricted Stock Units (RSU) financial
"The RSUs were granted in lieu of cash as payment for a portion"
derivative security financial
"transaction_action": "derivative exercise/conversion""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
in lieu of cash financial
"RSUs were granted in lieu of cash as payment for a portion"
Rule 10b5-1 financial
"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider equity compensation did MariMed (MRMD) director Allen David R receive?
Allen David R received 192,308 Restricted Stock Units on July 15, 2026 as compensation for a portion of his MariMed board fees. These RSUs vested immediately and converted one-for-one into 192,308 shares of common stock at no cash exercise price.
Do any RSUs from this MariMed (MRMD) award remain outstanding for Allen David R?
No RSUs from this award remain outstanding. The footnotes state that the 192,308 RSUs granted on July 15, 2026 vested upon grant and, accordingly, no RSUs remain outstanding under this award after their conversion into common shares.
Why were RSUs used instead of cash to compensate the MariMed (MRMD) director?
The company states the RSUs were granted in lieu of cash as payment for a portion of Allen David R’s fees for serving on MariMed’s Board of Directors, effectively delivering board compensation in equity rather than in cash.